| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 |
| filingDate |
2019-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2021-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2021512928-A |
| titleOfInvention |
Crystal form of 3,4-dihydrothieno [3,2-d] pyrimidine-based compound and its preparation method |
| abstract |
The present invention discloses a crystal form of a 3,4-dihydrothieno [3,2-d] pyrimidine-based compound and a method for preparing the same, and further discloses the use of the above-mentioned crystal form in the preparation of an anti-HCMV virus drug. [Selection diagram] None |
| priorityDate |
2018-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |